Clear cell carcinoma of the ovary: a review of the literature
about
Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectivesMedical treatment of early stage and rare histological variants of epithelial ovarian cancerNew and emerging factors in tumorigenesis: an overviewFertility-sparing surgery for early stage epithelial ovarian cancer.Overcoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma.Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.Clear cell carcinoma of the ovary associated with increased risk of venous thrombosis.Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma.Involved-field radiation therapy for locoregionally recurrent ovarian cancer.Targeted inhibition of FAK, PYK2 and BCL-XL synergistically enhances apoptosis in ovarian clear cell carcinoma cell lines.Expression and significance of CD44, CD47 and c-met in ovarian clear cell carcinomaFunctional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the OvaryMagnetic Resonance Imaging Characteristics of Ovarian Clear Cell Carcinoma.Comparison of Clinical Characteristic and Prognosis between Ovarian Clear Cell Carcinoma and Serous Carcinoma: A 10-Year Cohort Study of Chinese Patients.Antitumor effects of cecropin B-LHRH' on drug-resistant ovarian and endometrial cancer cells.Characteristics of Long-Term Survivors of Epithelial Ovarian CancerClinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survivalClear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression.Differential expression of argininosuccinate synthetase in serous and non-serous ovarian carcinomas.Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges.Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channelRuptured clear cell carcinoma of the ovary presenting as acute abdomen.Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma.Vesical clear cell adenocarcinoma arising from endometriosis: A mullerian tumor, indistinguishable from ovarian clear cell adenocarcinomaFunctional redundancy of the Notch pathway in ovarian cancer cell lines.Potential role of mTORC2 as a therapeutic target in clear cell carcinoma of the ovary.c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma.Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma.Targeting FXYD2 by cardiac glycosides potently blocks tumor growth in ovarian clear cell carcinoma.Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer.Class III b-tubulin overexpression in gynecologic tumors: implications for the choice of microtubule targeted agents?Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.Outcomes of fertility-sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary.Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?Prognostic Value of C-met Expression in Cholangiocarcinoma.Radiation Treatment in Women with Ovarian Cancer: Past, Present, and FutureMolecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures.
P2860
Q26775315-F10E0528-4F14-446F-8410-DDAD8D24CB04Q26777702-CD9E56B3-A316-4019-90A2-48DFFAFF9931Q26801253-C58BBD0E-0B09-4DB4-8266-DD56AA9A0EAAQ30249715-F98261FE-7A10-4741-89C3-1CCB6A593797Q30410498-74BB1874-49E7-4FDC-8DCE-C06C7657BCFFQ33734760-3DF64606-BFE8-4B98-B23E-AD19307A16EFQ33735170-23CAC419-F516-4FC1-B47E-23308DFCCE3CQ34632105-DEE5642B-BDE5-4E21-927D-D85039504551Q34998460-440B00AF-41FE-4E75-A8EA-A1DF5D93A892Q35019267-6C5BE7BE-813A-4AB1-9F1E-42EF75CB8BEAQ35093687-672CFE6D-C4CB-4066-BF98-34C56D7FF4AEQ35139055-CD06827C-C90D-4975-B3DD-B2466878CD7EQ35328194-7AD7BA5F-B6EE-4C4A-AAD0-09D789F36ADCQ35434007-5D2FFCBE-FEE4-4854-B774-D80642471583Q35687723-A9A1399D-FC23-4B25-8910-149D1C5E3D72Q35694661-1081B38F-F66B-4D95-827D-E03AE2547AD2Q35972278-1E9B3F64-05D6-4A97-B229-BDB12D171A1AQ35984294-F7000A57-E8B5-4930-9A1C-A9A2EA2E240EQ36178605-EDB967D4-6504-479D-B18A-29302BEBA649Q36413347-55844E3C-4C76-4E8B-93B4-784CF86537E5Q36529643-3B7FC6DA-9836-4EE4-A760-8295A4A6F58AQ36873800-425A57BD-0F15-43FF-8369-23876A24399BQ36949580-8E1F9DBA-D3C8-41FA-8547-D78B3AD46390Q36975149-EE99F5B8-CCF6-458A-986F-E56D7604EE3CQ36985104-6E5C7C3A-70CE-4DCE-A4DC-A3982745530DQ37064411-465C10E3-55E7-4039-9F42-60669746A53AQ37254057-9C1BFEBC-C679-4825-A8A3-2048CD92502FQ37289384-257CC00C-7274-4CE4-BD5F-F829FD4FC37AQ37367848-5F29620B-F1FB-4166-AFA0-AA26187FF03DQ37472110-A468D26D-C2FD-44DC-997F-166ED603DD70Q37477273-14308A31-6A9E-463E-A82D-F635C4D39D25Q37665204-6187916F-D1C1-401B-8226-7EB11438DB7BQ37709179-F468F8AA-D55C-4887-8A00-BAB387FEA8DDQ38069185-A8DA318D-ABFC-4E1C-8B07-65AD5742C39DQ38889364-4AA60527-4547-42DD-848B-25C75D634286Q39868756-D87B12B1-1D71-4364-89E6-EBA0DDFB7944Q40101724-A8B94C2A-83D9-4AFF-A3E8-2EAECC6A6349Q41073453-79D61003-1837-49A4-BB39-9B0C63E9FF30Q41487973-A424633D-9AD9-423D-8C91-0D6851DFDCBFQ41685127-70C347E7-2687-44B8-9EE9-1A1442FF51A5
P2860
Clear cell carcinoma of the ovary: a review of the literature
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Clear cell carcinoma of the ovary: a review of the literature
@ast
Clear cell carcinoma of the ovary: a review of the literature
@en
Clear cell carcinoma of the ovary: a review of the literature
@nl
type
label
Clear cell carcinoma of the ovary: a review of the literature
@ast
Clear cell carcinoma of the ovary: a review of the literature
@en
Clear cell carcinoma of the ovary: a review of the literature
@nl
prefLabel
Clear cell carcinoma of the ovary: a review of the literature
@ast
Clear cell carcinoma of the ovary: a review of the literature
@en
Clear cell carcinoma of the ovary: a review of the literature
@nl
P2093
P3181
P1433
P1476
Clear cell carcinoma of the ovary: a review of the literature
@en
P2093
John O Schorge
Marcela G del Carmen
Michael Birrer
P304
P3181
P356
10.1016/J.YGYNO.2012.04.021
P407
P577
2012-09-01T00:00:00Z